{"id":"https://openalex.org/W2582992809","doi":"https://doi.org/10.1182/blood.v112.11.4390.4390","title":"Clofarabine (Clo) +/\u2212 Fludarabine (Flu) with IV Busulfan (Bu) and Allogeneic Stem Cell Transplantation (Allo-SCT) for Relapsed, Refractory Myeloid Leukemia (ML) and MDS","display_name":"Clofarabine (Clo) +/\u2212 Fludarabine (Flu) with IV Busulfan (Bu) and Allogeneic Stem Cell Transplantation (Allo-SCT) for Relapsed, Refractory Myeloid Leukemia (ML) and MDS","publication_year":2008,"publication_date":"2008-11-16","ids":{"openalex":"https://openalex.org/W2582992809","doi":"https://doi.org/10.1182/blood.v112.11.4390.4390","mag":"2582992809"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v112.11.4390.4390","doi":"https://doi.org/10.1182/blood.v112.11.4390.4390","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v112.11.4390.4390","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004417292","display_name":"B\u00f6rje S. Andersson","orcid":"https://orcid.org/0000-0003-4761-0220","observed_orcids":["https://orcid.org/0000-0003-4761-0220"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Borje S. Andersson","raw_affiliation_strings":["Stem Cell Transplantation & Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stem Cell Transplantation & Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Marcos de Lima","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marcos de Lima","raw_affiliation_strings":["Stem Cell Transplantation & Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stem Cell Transplantation & Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113588479","display_name":"Laura L. Worth","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura L. Worth","raw_affiliation_strings":["Pediatrics, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pediatrics, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066894053","display_name":"Uday Popat","orcid":"https://orcid.org/0000-0002-7592-2224","observed_orcids":["https://orcid.org/0000-0002-7592-2224"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Uday Popat","raw_affiliation_strings":["Stem Cell Transplantation & Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stem Cell Transplantation & Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109241889","display_name":"Roy B. Jones","orcid":"https://orcid.org/0009-0007-7599-7668","observed_orcids":["https://orcid.org/0009-0007-7599-7668"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Roy B. Jones","raw_affiliation_strings":["Stem Cell Transplantation & Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stem Cell Transplantation & Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055885795","display_name":"Elizabeth J. Shpall","orcid":"https://orcid.org/0000-0003-3947-4126","observed_orcids":["https://orcid.org/0000-0003-3947-4126"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth J. Shpall","raw_affiliation_strings":["Stem Cell Transplantation & Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stem Cell Transplantation & Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050962913","display_name":"Chitra M. Hosing","orcid":"https://orcid.org/0000-0003-0409-5556","observed_orcids":["https://orcid.org/0000-0003-0409-5556"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chitra Hosing","raw_affiliation_strings":["Stem Cell Transplantation & Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stem Cell Transplantation & Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086839893","display_name":"Timothy L. Madden","orcid":"https://orcid.org/0000-0003-2954-4776","observed_orcids":["https://orcid.org/0000-0003-2954-4776"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Timothy Madden","raw_affiliation_strings":["Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091853246","display_name":"Reza Kazerooni","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Reza Kazerooni","raw_affiliation_strings":["Pharmacy Pharmacology Research, University of Texas M.D. Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacy Pharmacology Research, University of Texas M.D. Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056495325","display_name":"Patricia McAdams","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patricia McAdams","raw_affiliation_strings":["Stem Cell Transplantation & Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stem Cell Transplantation & Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034104852","display_name":"Amin Majid Alousi","orcid":"https://orcid.org/0000-0002-2498-8573","observed_orcids":["https://orcid.org/0000-0002-2498-8573"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amin Alousi","raw_affiliation_strings":["Stem Cell Transplantation & Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stem Cell Transplantation & Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069460930","display_name":"Partow Kebriaei","orcid":"https://orcid.org/0000-0002-8607-9404","observed_orcids":["https://orcid.org/0000-0002-8607-9404"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Partow Kebriaei","raw_affiliation_strings":["Stem Cell Transplantation & Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stem Cell Transplantation & Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048913229","display_name":"Richard E. Champlin","orcid":"https://orcid.org/0000-0002-4314-5037","observed_orcids":["https://orcid.org/0000-0002-4314-5037"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard E. Champlin","raw_affiliation_strings":["Stem Cell Transplantation & Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stem Cell Transplantation & Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.4312,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.70413766,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"112","issue":"11","first_page":"4390","last_page":"4390"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.8877000212669373,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.8877000212669373,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.10790000110864639,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/clofarabine","display_name":"clofarabine","score":0.9909999966621399},{"id":"https://openalex.org/keywords/fludarabine","display_name":"fludarabine","score":0.996999979019165},{"id":"https://openalex.org/keywords/busulfan","display_name":"busulfan","score":0.9919999837875366},{"id":"https://openalex.org/keywords/allogeneic-stem-cell-transplantation","display_name":"allogeneic stem cell transplantation","score":0.9399999976158142},{"id":"https://openalex.org/keywords/myeloid-leukemia","display_name":"myeloid leukemia","score":0.8569999933242798},{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.9520000219345093},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.8100000023841858},{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9869999885559082},{"id":"https://openalex.org/keywords/reduced-intensity-conditioning","display_name":"reduced-intensity conditioning","score":0.6790000200271606},{"id":"https://openalex.org/keywords/myeloablative-conditioning","display_name":"myeloablative conditioning","score":0.9610000252723694},{"id":"https://openalex.org/keywords/nucleoside-analogs","display_name":"nucleoside analogues","score":0.7940000295639038},{"id":"https://openalex.org/keywords/engraftment","display_name":"engraftment","score":0.7149999737739563},{"id":"https://openalex.org/keywords/relapsed-refractory-disease","display_name":"relapsed/refractory disease","score":0.7509999871253967},{"id":"https://openalex.org/keywords/conditioning-regimen","display_name":"conditioning regimen","score":0.3070000112056732}],"concepts":[{"id":"https://openalex.org/C2777198975","wikidata":"https://www.wikidata.org/wiki/Q5134875","display_name":"Clofarabine","level":4,"score":0.9525588750839233},{"id":"https://openalex.org/C2780611847","wikidata":"https://www.wikidata.org/wiki/Q348922","display_name":"Busulfan","level":4,"score":0.8193066120147705},{"id":"https://openalex.org/C2779263901","wikidata":"https://www.wikidata.org/wiki/Q185916","display_name":"Fludarabine","level":4,"score":0.8095952272415161},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7066190242767334},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.5987198352813721},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5946730971336365},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5389905571937561},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.4898359477519989},{"id":"https://openalex.org/C2777333352","wikidata":"https://www.wikidata.org/wiki/Q2689559","display_name":"Nucleoside analogue","level":3,"score":0.4728686511516571},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.43231943249702454},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4118344187736511},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4117946922779083},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4035974144935608},{"id":"https://openalex.org/C2777408962","wikidata":"https://www.wikidata.org/wiki/Q1128050","display_name":"Hematopoietic stem cell transplantation","level":3,"score":0.35452231764793396},{"id":"https://openalex.org/C2778041864","wikidata":"https://www.wikidata.org/wiki/Q180983","display_name":"Cytarabine","level":3,"score":0.3180314004421234},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.12475574016571045},{"id":"https://openalex.org/C2776543447","wikidata":"https://www.wikidata.org/wiki/Q28734","display_name":"Nucleoside","level":2,"score":0.12063971161842346},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.10274240374565125},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v112.11.4390.4390","doi":"https://doi.org/10.1182/blood.v112.11.4390.4390","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v112.11.4390.4390","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2087693871","https://openalex.org/W1974632374","https://openalex.org/W2009969425","https://openalex.org/W2312402341","https://openalex.org/W2466681359","https://openalex.org/W2558094369","https://openalex.org/W2565568893","https://openalex.org/W3095129285","https://openalex.org/W2530046292","https://openalex.org/W2980027649"],"abstract_inverted_index":{"Abstract":[0],"Fludarabine":[1],"(Flu)":[2],"combined":[3,64,524],"with":[4,30,65,164,195,389,405,433,450,525],"IV":[5,66,112,526],"Busulfan":[6],"(Bu)":[7],"is":[8,50],"a":[9,33,56,69,165,209,217,232,342,357,370,406,434,478],"safe,":[10],"reduced":[11],"toxicity":[12,292],"pretransplant":[13,531],"conditioning":[14,23,532],"program.":[15],"To":[16],"enhance":[17],"the":[18,22,75,80,86,118,226,286,290,300,386,497,519],"cytoreductive":[19],"effect":[20],"of":[21,45,147,168,221,277,344,359,372,385,409,469,500,504,522],"regimen,":[24],"we":[25,54],"decided":[26],"to":[27,142,431,516],"replace":[28,62],"Flu":[29,63],"Clofarabine":[31],"(Clo),":[32],"(superior)":[34],"second":[35,182,210,421],"generation":[36],"nucleoside":[37,119],"analog/antileukemic":[38],"agent,":[39],"whose":[40],"immunosuppressive":[41,498],"capability":[42,499],"in":[43,68,200,204,216,285,297,380,400,420,453,483,502,506],"support":[44,503],"allogeneic":[46],"progenitor":[47],"cell":[48],"engraftment":[49],"unknown.":[51],"In":[52],"2006":[53],"initiated":[55],"trial":[57],"where":[58],"Clo":[59,114,338,501,523],"would":[60],"gradually":[61],"Bu":[67,137,527],"myeloablative":[70],"program,":[71],"aimed":[72],"at":[73,115,330,392,426,466],"retaining":[74],"safety":[76],"profile,":[77],"while":[78,246],"evaluating":[79],"engraftment-promoting":[81],"capacity,":[82],"and":[83,90,110,161,185,223,240,257,259,325,396,443,456,463,471,509,537],"hopefully":[84],"improving":[85],"antileukemic":[87,520],"activity.":[88],"METHODS":[89],"PATIENTS:":[91],"Patients":[92],"were":[93,199,238],"enrolled/randomized":[94],"as":[95,530],"follows:":[96],"Arm":[97,102,106,111],"I:":[98],"Clo:Flu":[99],"10:30":[100],"mg/m2,":[101,105,109,117],"II":[103],"20:20":[104],"III":[107],"30:10":[108],"single-agent":[113],"40":[116],"analog(s)":[120],"were/was":[121],"infused":[122,138],"over":[123,139],"60":[124],"min":[125],"each":[126,133],"once":[127],"daily":[128,145],"for":[129,534],"4":[130,241,427],"days":[131],"on":[132,255],"day":[134,322,331,365],"followed":[135],"by":[136,424],"3":[140,198,203],"hours":[141],"an":[143,263],"average":[144],"AUC":[146],"6,000":[148],"mcMol-min":[149],"+/\u2212":[150],"10%.":[151],"So":[152],"far,":[153],"20":[154],"patients":[155,174,191,229,314,388,398,452],"have":[156],"been":[157,448],"enrolled,":[158],"12":[159],"males":[160],"8":[162,410],"females,":[163],"median":[166,343,358,371,407],"age":[167],"43":[169],"years":[170],"(range:":[171],"6\u201357).":[172],"Seven":[173],"had":[175,192,208,231,242,248,262,318,341,356,369],"CML":[176,417],"(BC:":[177],"1,":[178],"first":[179,187,287],"AP:":[180,183],"3,":[181],"2,":[184],"late":[186],"CP:":[188],"1).":[189],"Thirteen":[190],"AML:":[193],"5":[194],"induction":[196],"failure,":[197],"chemotherapy-refractory":[201],"relapse,":[202,206],"untreated":[205],"1":[207,214,230],"PR,":[211],"and,":[212],"finally":[213],"was":[215,253,280,293,304],"high-risk":[218,486],"CR1":[219],"[cytogenetics":[220],"\u22127":[222],"t(3;12)].":[224],"Of":[225],"13":[227],"AML":[228,320],"favorable":[233],"cytogenetic":[234],"(CG)":[235],"pattern,":[236],"6":[237,378],"intermediate,":[239],"poor":[243],"prognosis":[244],"CG,":[245],"2":[247],"unknown":[249],"CG":[250,425,436],"data.":[251],"GVHD-prophylaxis":[252],"based":[254],"tacrolimus":[256],"mini-MTX,":[258],"those":[260],"who":[261],"unrelated":[264],"or":[265,308,493],"one":[266,467],"antig-mism.":[267],"related":[268],"donor":[269,348],"received":[270],"rabbit-ATG":[271],"(Thymoglobulin\u2122).":[272],"RESULTS:":[273],"One":[274,414],"patient":[275,418],"died":[276],"pneumonia,":[278],"there":[279,303,489],"no":[281,305,494],"other":[282],"treatment-related":[283],"death":[284],"100":[288],"days,":[289],"main":[291],"mucositis":[294],"grade":[295],"2\u20133":[296],"about":[298,496],"half":[299],"patients.":[301,383],"Specifically":[302],"significant":[306],"hepatic":[307],"neurologic":[309],"toxicity.":[310],"All":[311],"19":[312,387],"evaluable":[313,382],"engrafted":[315],"uneventfully":[316],"(one":[317],"recurrent":[319],"before":[321],"+30).":[323],"Marrow":[324],"blood":[326],"(T-cell)":[327],"chimerism":[328],"studies":[329],"+30":[332],"revealed":[333],"that":[334,477],"groups":[335,351],"I+II":[336],"(lower":[337],"doses;":[339],"n=9)":[340],"87%":[345],"(range":[346],"17\u2013100)":[347],"(T-cell)-derived":[349],"DNA,":[350,375],"III+IV":[352],"(higher":[353],"Clo-doses,":[354],"n=11)":[355],"100%":[360,373],"range":[361],"(64\u2013100)":[362],"donor-DNA.":[363],"By":[364],"+100":[366],"both":[367],"cohorts":[368],"donor-derived":[374],"maintained":[376,435],"beyond":[377],"months":[379],"all":[381],"16":[384],"active":[390],"disease":[391],"SCT":[393],"entered":[394],"CR,":[395,455],"11":[397,451],"remain":[399],"clinical":[401],"CR":[402,437],"(August":[403],"2008)":[404],"duration":[408],"mos":[411],"(range,":[412],"2\u201319).":[413],"previously":[415],"TKI-resistant":[416],"(SCT":[419],"AP)":[422],"progressed":[423],"mos,":[428],"but":[429],"responded":[430],"dasatinib,":[432],"exceeding":[438],"22":[439],"mos.":[440],"Median":[441],"disease-free":[442,464],"overall":[444,462],"survival":[445,465],"has":[446],"not":[447],"reached":[449],"unmaintained":[454],"12/20":[457],"being":[458],"alive.":[459],"The":[460],"projected":[461],"year":[468],"70%":[470],"55%,":[472],"respectively.":[473],"CONCLUSION:":[474],"We":[475],"conclude":[476],"Clo-Bu-based":[479],"regimen":[480],"appears":[481],"safe":[482],"(relapsed,":[484],"chemotherapy-refractory)":[485],"patients,":[487],"2)":[488],"should":[490],"be":[491],"little":[492],"concern":[495],"allo-SCT":[505],"myeloid":[507,535],"leukemia,":[508],"3)":[510],"(an)":[511],"additional":[512],"study(-ies)":[513],"is/(are)":[514],"warranted":[515],"fully":[517],"evaluate":[518],"efficacy":[521],"+":[528],"ATG":[529],"therapy":[533],"leukemia":[536],"MDS.":[538]},"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2017-02-03T00:00:00"}